Summary
| Name | HLA-DRAView Modifications |
| Full Name | HLA class II histocompatibility antigen, DR alpha chain |
| Synonyms | MHC class II antigen DRA | HLA-DRA1 |
| Primary ID | P01903 |
| Links | - - ![]() |
| Type | protein |
| Relations | 9 |
| Pathways | EBV infection |
| Function | An alpha chain of antigen-presenting major histocompatibility complex class II (MHCII) molecule. In complex with the beta chain HLA-DRB, displays antigenic peptides on professional antigen presenting cells (APCs) for recognition by alpha-beta T cell receptor (TCR) on HLA-DR-restricted CD4-positive T cells. This guides antigen-specific T-helper effector functions, both antibody-mediated immune response and macrophage activation, to ultimately eliminate the infectious agents and transformed cells (PubMed:29884618, PubMed:17334368, PubMed:8145819, PubMed:15322540, PubMed:22327072, PubMed:27591323, PubMed:31495665, PubMed:15265931, PubMed:9075930, PubMed:24190431). Typically presents extracellular peptide antigens of 10 to 30 amino acids that arise from proteolysis of endocytosed antigens in lysosomes (PubMed:8145819). In the tumor microenvironment, presents antigenic peptides that are primarily generated in tumor-resident APCs likely via phagocytosis of apoptotic tumor cells or macropinocytosis of secreted tumor proteins (PubMed:31495665). Presents peptides derived from intracellular proteins that are trapped in autolysosomes after macroautophagy, a mechanism especially relevant for T cell selection in the thymus and central immune tolerance (PubMed:17182262, PubMed:23783831). The selection of the immunodominant epitopes follows two processing modes |
Viewer
Search Tools
Refine search:
- by mechanism
- by effect
- by organism:
- by tissue:
- by cell-line
Modifications Tables
Relations
| Regulator | Mechanism | target | score ℹ | |
|---|---|---|---|---|
| + | MARCHF8 | down-regulates quantity by destabilization
polyubiquitination
|
HLA-DRA | 0.2 |
| Publications: | 1 | Organism: | Homo Sapiens | |
| + | MARCHF1 | down-regulates quantity by destabilization
polyubiquitination
|
HLA-DRA | 0.2 |
| Publications: | 1 | Organism: | Homo Sapiens | |
| + | RFX complex | up-regulates quantity by expression
transcriptional regulation
|
HLA-DRA | 0.415 |
| Publications: | 2 | Organism: | In Vitro, Homo Sapiens | |
| + | HLA-DRA | up-regulates
|
Membrane_fusion | 0.7 |
| Publications: | 1 | Organism: | Homo Sapiens | |
| Pathways: | EBV infection | |||
| + | NFX1 | down-regulates quantity by repression
transcriptional regulation
|
HLA-DRA | 0.398 |
| Publications: | 1 | Organism: | Homo Sapiens | |
| + | RFX5 | up-regulates quantity by expression
transcriptional regulation
|
HLA-DRA | 0.502 |
| Publications: | 1 | Organism: | Homo Sapiens | |
| + | EBV gH:gL:gp42 | up-regulates activity
binding
|
HLA-DRA | 0.2 |
| Publications: | 1 | Organism: | Homo Sapiens | |
| Pathways: | EBV infection | |||
| + | CIITA | up-regulates quantity by expression
transcriptional regulation
|
HLA-DRA | 0.621 |
| Publications: | 1 | Organism: | Homo Sapiens | |
4.0
HLA-DRA


polyubiquitination
transcriptional regulation
transcriptional regulation